Safety and efficacy of apixaban versus warfarin in patients with end-stage renal disease: Meta-analysis

被引：16

作者：

Chokesuwattanaskul, Ronpichai ^{[1
,2
]}

Thongprayoon, Charat ^{[3
]}

Tanawuttiwat, Tanyanan ^{[4
]}

Kaewput, Wisit ^{[5
]}

Pachariyanon, Pavida ^{[6
]}

Cheungpasitporn, Wisit ^{[7
]}

机构：

[1] Chulalongkorn Univ, Fac Med, Dept Med, Div Cardiol, Bangkok, Thailand

[2] King Chulalongkorn Mem Hosp, Bangkok, Thailand

[3] Bassett Med Ctr, Dept Internal Med, Cooperstown, NY USA

[4] Univ Mississippi, Med Ctr, Dept Med, Div Cardiol, Jackson, MS 39216 USA

[5] Phramongkutklao Coll Med Bangkok, Dept Mil & Community Med, Bangkok, Thailand

[6] Texas Tech Univ, Hlth Sci Ctr, Dept Internal Med, Lubbock, TX 79430 USA

[7] Univ Mississippi, Med Ctr, Dept Med, Div Nephrol, Jackson, MS 39216 USA

来源：

PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY | 2018年 / 41卷 / 07期

关键词：

apixaban; atrial fibrillation; bleeding complication; meta-analysis; thromboembolic events; vitamin K antagonist; warfarin;

D O I：

10.1111/pace.13390

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：878 / 878

页数：1

共 6 条